Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | recQ family helicase, putative | 0.0013 | 0.0536 | 0.2195 |
Echinococcus multilocularis | tar DNA binding protein | 0.0069 | 0.4439 | 0.4246 |
Echinococcus granulosus | tar DNA binding protein | 0.0069 | 0.4439 | 0.4377 |
Echinococcus granulosus | bloom syndrome protein | 0.0024 | 0.1307 | 0.1036 |
Treponema pallidum | ATP-dependent DNA helicase | 0.0005 | 0.00000000028166 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0052 | 0.3211 | 0.2976 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.2085 | 0.2085 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0044 | 0.2695 | 1 |
Trypanosoma cruzi | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0013 | 0.0536 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0052 | 0.3211 | 0.2976 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0016 | 0.0778 | 0.0473 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0778 | 0.0778 |
Loa Loa (eye worm) | RNA binding protein | 0.0069 | 0.4439 | 0.4439 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0016 | 0.0778 | 0.0458 |
Schistosoma mansoni | tar DNA-binding protein | 0.0069 | 0.4439 | 0.4439 |
Plasmodium falciparum | ADP-dependent DNA helicase RecQ | 0.0021 | 0.1106 | 0.3659 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0016 | 0.0778 | 0.0473 |
Schistosoma mansoni | DNA helicase recq1 | 0.001 | 0.0335 | 0.0335 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0044 | 0.2695 | 0.2517 |
Loa Loa (eye worm) | acetyltransferase | 0.015 | 1 | 1 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0044 | 0.2695 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.3211 | 0.3211 |
Schistosoma mansoni | tar DNA-binding protein | 0.0069 | 0.4439 | 0.4439 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0035 | 0.2085 | 0.1811 |
Brugia malayi | Bloom's syndrome protein homolog | 0.0024 | 0.1307 | 0.1005 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.001 | 0.0335 | 0.1243 |
Echinococcus granulosus | GPCR family 2 | 0.0016 | 0.0778 | 0.0473 |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.0019 | 0.0958 | 0.0958 |
Plasmodium falciparum | histone acetyltransferase GCN5 | 0.004 | 0.2441 | 1 |
Brugia malayi | TAR-binding protein | 0.0069 | 0.4439 | 0.4246 |
Schistosoma mansoni | DNA helicase recq5 | 0.001 | 0.0335 | 0.0335 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.0778 | 0.0778 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0016 | 0.0778 | 0.0458 |
Loa Loa (eye worm) | TAR-binding protein | 0.0069 | 0.4439 | 0.4439 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.0778 | 0.0778 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0024 | 0.1307 | 0.357 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0052 | 0.3211 | 0.3211 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.015 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0335 | 0.0335 |
Schistosoma mansoni | tar DNA-binding protein | 0.0069 | 0.4439 | 0.4439 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.0778 | 0.0778 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.0024 | 0.1307 | 0.357 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0146 | 0.971 | 1 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0044 | 0.2695 | 1 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0016 | 0.0778 | 0.0778 |
Echinococcus multilocularis | GPCR, family 2 | 0.0016 | 0.0778 | 0.0458 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0069 | 0.4439 | 0.4439 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0016 | 0.0778 | 0.0458 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.0778 | 0.0778 |
Loa Loa (eye worm) | RecQ helicase | 0.0024 | 0.1307 | 0.1307 |
Loa Loa (eye worm) | hypothetical protein | 0.0121 | 0.7981 | 0.7981 |
Leishmania major | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0013 | 0.0536 | 0.5 |
Echinococcus multilocularis | bloom syndrome protein | 0.0024 | 0.1307 | 0.1005 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.2085 | 0.2085 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0044 | 0.2695 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0069 | 0.4439 | 0.4439 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.015 | 1 | 1 |
Loa Loa (eye worm) | ATP-dependent DNA helicase | 0.001 | 0.0335 | 0.0335 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.001 | 0.0335 | 0.1243 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0069 | 0.4439 | 0.4246 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0044 | 0.2695 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0016 | 0.0778 | 0.0458 |
Trypanosoma brucei | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0013 | 0.0536 | 0.5 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.004 | 0.2441 | 1 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0016 | 0.0757 | 0.2811 |
Schistosoma mansoni | tar DNA-binding protein | 0.0069 | 0.4439 | 0.4439 |
Brugia malayi | RNA binding protein | 0.0069 | 0.4439 | 0.4246 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.004 | 0.2441 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | > 1 mM | Inhibition of glutamate carboxypeptidase 2 in human LNCaP cells by fluorescence based NAALADase assay | ChEMBL. | 19897367 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.